Joincare Pharmaceutical Group Industry Co.,Ltd. revenue reports
Joincare Pharmaceutical Group Industry Co.,Ltd. financial reports, Joincare Pharmaceutical Group Industry Co.,Ltd. annual revenue in 2024. When does Joincare Pharmaceutical Group Industry Co.,Ltd. report revenue?
Joincare Pharmaceutical Group Industry Co.,Ltd. total revenue, net income and dynamics of changes in yuan today
Joincare Pharmaceutical Group Industry Co.,Ltd. current income and income for the latest reporting periods. Net revenue Joincare Pharmaceutical Group Industry Co.,Ltd. is now 4 144 871 763 ¥. Information about net revenue is taken from open sources. The dynamics of Joincare Pharmaceutical Group Industry Co.,Ltd. net income rose by 173 921 108 ¥. The assessment of the dynamics of Joincare Pharmaceutical Group Industry Co.,Ltd. net income was made in comparison with the previous report. Graph of the financial report of Joincare Pharmaceutical Group Industry Co.,Ltd.. Joincare Pharmaceutical Group Industry Co.,Ltd. financial report on the graph shows the dynamics of assets. A graph of the value of all Joincare Pharmaceutical Group Industry Co.,Ltd. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
4 144 871 763 ¥
+24.03 % ↑
366 890 020 ¥
+20.1 % ↑
31/12/2020
3 418 576 441 ¥
+33.14 % ↑
192 968 912 ¥
+232.5 % ↑
30/09/2020
3 627 326 421 ¥
+20.67 % ↑
251 205 667 ¥
+8.11 % ↑
30/06/2020
3 288 535 079 ¥
+11.74 % ↑
396 407 147 ¥
+64.59 % ↑
30/09/2019
3 006 071 131 ¥
-
232 361 104 ¥
-
30/06/2019
2 942 900 093 ¥
-
240 843 239 ¥
-
31/03/2019
3 341 809 272 ¥
-
305 486 811 ¥
-
31/12/2018
2 567 708 513 ¥
-
58 035 509 ¥
-
Show:
to
Joincare Pharmaceutical Group Industry Co.,Ltd. financial report charts
The latest dates of Joincare Pharmaceutical Group Industry Co.,Ltd. financial statements available online: 31/12/2018, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Joincare Pharmaceutical Group Industry Co.,Ltd. is available online for such a date - 31/03/2021. Gross profit Joincare Pharmaceutical Group Industry Co.,Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Joincare Pharmaceutical Group Industry Co.,Ltd. is 2 696 500 269 ¥
Joincare Pharmaceutical Group Industry Co.,Ltd. quarterly report dates
Cost of revenue Joincare Pharmaceutical Group Industry Co.,Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Joincare Pharmaceutical Group Industry Co.,Ltd. is 1 448 371 494 ¥ Total revenue Joincare Pharmaceutical Group Industry Co.,Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Joincare Pharmaceutical Group Industry Co.,Ltd. is 4 144 871 763 ¥ Operating income Joincare Pharmaceutical Group Industry Co.,Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Joincare Pharmaceutical Group Industry Co.,Ltd. is 787 971 982 ¥
Net income Joincare Pharmaceutical Group Industry Co.,Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Joincare Pharmaceutical Group Industry Co.,Ltd. is 366 890 020 ¥ Current assets Joincare Pharmaceutical Group Industry Co.,Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Joincare Pharmaceutical Group Industry Co.,Ltd. is 18 833 239 635 ¥ Total assets Joincare Pharmaceutical Group Industry Co.,Ltd. refers to the total amount of assets owned by a person or entity. Total assets Joincare Pharmaceutical Group Industry Co.,Ltd. is 28 594 081 547 ¥
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 696 500 269 ¥
2 055 362 177 ¥
2 323 949 355 ¥
2 122 886 184 ¥
1 949 472 913 ¥
1 899 743 047 ¥
2 217 689 178 ¥
1 470 834 986 ¥
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 448 371 494 ¥
1 363 214 264 ¥
1 303 377 066 ¥
1 165 648 895 ¥
1 056 598 218 ¥
1 043 157 046 ¥
1 124 120 094 ¥
1 096 873 527 ¥
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
4 144 871 763 ¥
3 418 576 441 ¥
3 627 326 421 ¥
3 288 535 079 ¥
3 006 071 131 ¥
2 942 900 093 ¥
3 341 809 272 ¥
2 567 708 513 ¥
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
3 006 071 131 ¥
2 942 900 093 ¥
3 341 809 272 ¥
2 567 708 513 ¥
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
787 971 982 ¥
299 901 524 ¥
602 496 054 ¥
870 960 873 ¥
553 108 431 ¥
409 486 625 ¥
647 635 941 ¥
74 031 042 ¥
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
366 890 020 ¥
192 968 912 ¥
251 205 667 ¥
396 407 147 ¥
232 361 104 ¥
240 843 239 ¥
305 486 811 ¥
58 035 509 ¥
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
289 399 163 ¥
375 989 923 ¥
323 198 816 ¥
211 720 588 ¥
219 739 529 ¥
188 282 453 ¥
171 337 367 ¥
256 804 492 ¥
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
3 356 899 781 ¥
3 118 674 917 ¥
3 024 830 367 ¥
2 417 574 206 ¥
2 452 962 700 ¥
2 533 413 468 ¥
2 694 173 331 ¥
2 493 677 471 ¥
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
18 833 239 635 ¥
18 404 555 036 ¥
17 056 860 140 ¥
15 244 768 174 ¥
14 914 421 342 ¥
15 154 384 712 ¥
15 202 822 246 ¥
16 575 011 651 ¥
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
28 594 081 547 ¥
28 156 977 585 ¥
26 349 453 578 ¥
24 308 088 320 ¥
23 795 846 128 ¥
23 900 575 081 ¥
23 926 037 478 ¥
24 985 756 532 ¥
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
11 948 809 559 ¥
12 289 098 613 ¥
10 450 484 533 ¥
8 949 392 666 ¥
9 302 706 426 ¥
9 622 518 761 ¥
9 675 613 510 ¥
11 471 255 268 ¥
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
6 069 995 373 ¥
6 646 077 467 ¥
5 924 603 335 ¥
7 636 017 262 ¥
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
6 672 705 271 ¥
7 252 259 658 ¥
7 011 580 762 ¥
8 688 722 523 ¥
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
28.04 %
30.34 %
29.31 %
34.77 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
11 361 503 445 ¥
11 096 125 891 ¥
10 841 960 286 ¥
10 525 325 159 ¥
10 311 373 657 ¥
10 084 159 542 ¥
10 081 902 231 ¥
9 643 518 714 ¥
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
650 210 540 ¥
575 936 234 ¥
555 698 292 ¥
832 167 304 ¥
Last revenue report of Joincare Pharmaceutical Group Industry Co.,Ltd. was 31/03/2021. According to last financial report total revenue in Joincare Pharmaceutical Group Industry Co.,Ltd. was 4 144 871 763 yuan and changed by +24.03% since last year. Net income in Joincare Pharmaceutical Group Industry Co.,Ltd. was 366 890 020 ¥ in last quartal, net income changes to +20.1%.
Current cash Joincare Pharmaceutical Group Industry Co.,Ltd. - the sum of all of the cash a company has on the date of report. Current cash Joincare Pharmaceutical Group Industry Co.,Ltd. is 11 948 809 559 ¥
Joincare Pharmaceutical Group Industry Co.,Ltd. stocks data
600380.SS stock price
Joincare Pharmaceutical Group Industry Co.,Ltd. stock price today, 600380.SS stock quote.
